Frontage Expands Clinical Operations in Secaucus, NJ

EXTON, Pa.--()--Frontage, a full service contract research organization (CRO), today announced the opening of its newest facility in Secaucus, NJ to expand its clinical research portfolio of services.

As part of Frontage’s strategic growth plans to broaden clinical service capabilities and increase capacity, the company has completed construction of its new 36,000-square-foot state-of-the-art 160-bed clinical research center in Secaucus, NJ. The location of the new facility complements the existing center in nearby Hackensack. The Secaucus facility will include the ability to conduct a wider range of clinical studies including multiple concurrent studies and Phase II-IV studies involving patient populations. This expansion will nearly triple the company’s clinical capacity in the USA.

“We are excited to operate a second facility in New Jersey as it has been an ideal location for our clinical research due to the immediate access to the medical communities as well as subject and patient populations,” said Eileen McAuley, Senior Vice President of Clinical Services.

“Frontage’s ability to provide comprehensive support to our clients and their needs in the early drug development stage is greatly enhanced by our investment in facility expansion and clinical services infrastructure,” said Dr. Song Li, CEO of Frontage.

About Frontage

Frontage is a global CRO that provides comprehensive, IND-enabling development services from drug metabolism, drug delivery through late stage clinical support with operation centers in the USA and Asia. Frontage’s clinical services include the design and conduct of studies in healthy volunteers and various patient populations, supported by an experienced team of industry professionals. Frontage also offers DMPK, CMC drug development activities, bioanalytical, and biometric services (including biostatistics, data management and medical writing) that facilitate drug development programs from concept to commercialization.

Contacts

Frontage Laboratories, Inc.
Meredith Faragalli, Marketing
484-348-4813
mfaragalli@frontagelab.com

Release Summary

Frontage announces the opening of their newest clinical research center in Secaucus, NJ. The new facility will have 160 beds throughout the 36,000-square-foot floor plan.

Contacts

Frontage Laboratories, Inc.
Meredith Faragalli, Marketing
484-348-4813
mfaragalli@frontagelab.com